Literature DB >> 16540961

Enoxaparin inhibits fibrin sheath formation and decreases central venous catheter colonization following bacteremic challenge.

Jennifer E Keller1, Jason W Hindman, John R Mehall, Samuel D Smith.   

Abstract

OBJECTIVE: Inhibition of fibrin sheath formation by enoxaparin decreases catheter colonization. Fibrin-binding radioactive tracer and catheter weights quantify fibrin reduction.
DESIGN: Controlled experimental study of central venous line colonization.
SETTING: Animal laboratory.
SUBJECTS: Adult male Sprague-Dawley rats.
INTERVENTIONS: Central venous lines were introduced into right external jugular veins of 254 animals in three groups: enoxaparin, Fibrimage, and catheter weight. The enoxaparin group (n = 196) received daily enoxaparin injections (n = 97) or catheter implantation only (n = 99); 176 received tail vein injections of Staphylococcus epidermidis on postoperative day (POD) 10. Twenty rats received saline injections as a control. On POD 13, catheters were removed and incubated in broth at 37 degrees C for 48 hrs. Turbid samples were plated. In the Fibrimage group (n = 39), 20 rats receiving enoxaparin were compared with 19 controls without enoxaparin; all received S. epidermidis injections on POD 10. Fibrimage, fibrin-binding radiolabeled tracer, was given 1 hr before catheter removal. In the weight group (n = 19), six rats received enoxaparin; 13 did not. All received injections of S. epidermidis on POD 10.
MEASUREMENTS AND MAIN RESULTS: Positive plates underwent analytic profile index testing, ensuring correlation with inoculum. Results were compared using Fisher's exact or chi-square tests. Gamma counts were determined in the Fibrimage group. Catheter tip weights were recorded. Results from the Fibrimage and weight groups were compared using Student's t-test. The enoxaparin group had fewer catheters colonized (17 of 77) vs. no enoxaparin (42 of 99; p < .01). Pericatheter sheaths contained less fibrin compared with controls. Fibrimage group gamma counts were significantly decreased for the enoxaparin subgroup (x = 2244 counts per minute) vs. controls (x = 3767 counts per minute; p < .0002). The weight of catheter tips treated with enoxaparin (x = 39 mg) vs. controls (x = 90 mg) was also significantly decreased (p < .0001).
CONCLUSIONS: Enoxaparin decreases the amount of fibrin surrounding central venous catheters. The incidence of catheter colonization decreases when the amount of fibrin within the pericatheter sheath decreases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16540961     DOI: 10.1097/01.CCM.0000215832.40827.71

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Fibrin sheath angioplasty: a technique to prevent superior vena cava stenosis secondary to dialysis catheters.

Authors:  Robert I Hacker; Lorena De Marco Garcia; Ankur Chawla; Thomas F Panetta
Journal:  Int J Angiol       Date:  2012-09

2.  Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter model.

Authors:  Carolyn R Schaeffer; Keith M Woods; G Matt Longo; Megan R Kiedrowski; Alexandra E Paharik; Henning Büttner; Martin Christner; Robert J Boissy; Alexander R Horswill; Holger Rohde; Paul D Fey
Journal:  Infect Immun       Date:  2014-10-20       Impact factor: 3.441

3.  The role of tissue plasminogen activator use and systemic hypercoagulability in central line-associated bloodstream infections.

Authors:  Kinna Thakarar; Matthew Collins; Lana Kwong; Carol Sulis; Cathy Korn; Nahid Bhadelia
Journal:  Am J Infect Control       Date:  2014-02-20       Impact factor: 2.918

4.  New materials and devices for preventing catheter-related infections.

Authors:  Jean-François Timsit; Yohann Dubois; Clémence Minet; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Rebecca Hamidfar-Roy; Carole Schwebel
Journal:  Ann Intensive Care       Date:  2011-08-18       Impact factor: 6.925

5.  An engineered micropattern to reduce bacterial colonization, platelet adhesion and fibrin sheath formation for improved biocompatibility of central venous catheters.

Authors:  Rhea M May; Chelsea M Magin; Ethan E Mann; Michael C Drinker; John C Fraser; Christopher A Siedlecki; Anthony B Brennan; Shravanthi T Reddy
Journal:  Clin Transl Med       Date:  2015-02-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.